Safety and efficacy of idarucizumab in terms of reversal of dabigatran in patients undergoing heart transplantation
Latest Information Update: 14 Oct 2019
At a glance
- Drugs Idarucizumab (Primary)
- Indications Blood coagulation disorders
- Focus Adverse reactions; Therapeutic Use
- 14 Oct 2019 New trial record